Mainz Biomed BV
NASDAQ:MYNZ
Mainz Biomed BV
NASDAQ:MYNZ
Price:
0.6
USD
5.26%
Market Closed
Market Cap:
$5.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mainz Biomed BV
NASDAQ:MYNZ
|
DE |
|
D
|
Daheng New Epoch Technology Inc
SSE:600288
|
CN |
|
H
|
Ha Noi South Housing and Urban Development Corp
VN:NHA
|
VN |
|
H
|
Haffner Energy SA
PAR:ALHAF
|
FR |
|
Adler Real Estate AG
XETRA:ADL
|
DE |
|
Royal Mail PLC
LSE:RMG
|
UK |
|
X
|
XiAn High Voltage Apparatus Research Institute Co Ltd
SSE:688334
|
CN |
Income Statement
Earnings Waterfall
Mainz Biomed BV
Mainz Biomed BV
Income Statement
Mainz Biomed BV
Mainz Biomed BV
Currency: USD
| Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
1
|
1
|
1
|
1
|
|
| Revenue |
1
N/A
|
1
+2%
|
1
-3%
|
1
-26%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
1
N/A
|
1
+6%
|
1
+6%
|
0
-23%
|
|
| Operating Income | |||||
| Operating Expenses |
(27)
|
(23)
|
(19)
|
(17)
|
|
| Selling, General & Administrative |
(17)
|
(15)
|
(13)
|
(11)
|
|
| Research & Development |
(9)
|
(6)
|
(5)
|
(5)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
|
| Operating Income |
(27)
N/A
|
(22)
+17%
|
(18)
+16%
|
(17)
+8%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
|
| Total Other Income |
1
|
1
|
(2)
|
(1)
|
|
| Pre-Tax Income |
(26)
N/A
|
(23)
+14%
|
(22)
+4%
|
(19)
+12%
|
|
| Net Income | |||||
| Income from Continuing Operations |
(26)
|
(23)
|
(22)
|
(19)
|
|
| Net Income (Common) |
(26)
N/A
|
(23)
+14%
|
(22)
+4%
|
(19)
+12%
|
|
| EPS (Diluted) |
-64.76
N/A
|
-40.28
+38%
|
-22.36
+44%
|
-6.03
+73%
|
|
Switch to:
Switch to:
See Also
Discover More
